Equqline Extra Strength Antacid Assorted Fruit

Description

This product is identified by NDC 41163-125-22 and is formulated as an extra strength antacid tablet. Each tablet contains 750 mg of Calcium Carbonate as the active ingredient, which is effective in providing relief from heartburn and acid indigestion. The tablets are available in assorted fruit flavors and are packaged in a bottle containing 96 chewable tablets.

Uses and Indications

This drug is indicated for the relief of acid indigestion and heartburn.

There are no teratogenic effects associated with this drug, nor are there any nonteratogenic effects mentioned.

Dosage and Administration

Adults and children 12 years of age and over are instructed to chew 2 to 4 tablets as symptoms occur, or as directed by a healthcare professional. It is recommended that the tablets be chewed thoroughly before swallowing to ensure optimal absorption and efficacy.

Contraindications

Use of this product is contraindicated in patients who exceed the maximum dosage of 10 tablets within a 24-hour period or who utilize the maximum dosage for more than 2 weeks without the advice and supervision of a healthcare professional.

Warnings and Precautions

Healthcare professionals should be aware of the following precautions associated with the use of this product.

General precautions must be observed to ensure patient safety. It is imperative that patients do not exceed a maximum dosage of 10 tablets within a 24-hour period. Additionally, the maximum dosage should not be utilized for more than 2 weeks unless under the guidance and supervision of a qualified healthcare provider. This precaution is essential to mitigate the risk of potential adverse effects associated with prolonged use or excessive dosing.

No specific laboratory tests or emergency medical help instructions are provided in the current guidelines. However, healthcare professionals should remain vigilant and monitor patients for any signs of adverse reactions or complications that may arise during treatment.

Side Effects

Patients should be aware of potential adverse reactions associated with the use of this medication. While specific adverse reactions have not been detailed, it is important to note that interactions may occur with other medications. For instance, patients currently taking prescription drugs should exercise caution, as antacids may interact with certain prescription medications, potentially altering their effectiveness or leading to unintended side effects.

Healthcare providers are encouraged to monitor patients for any unusual symptoms or reactions, particularly in those who are on concurrent therapies. It is advisable for patients to discuss their complete medication regimen with their healthcare provider to mitigate the risk of adverse interactions.

Drug Interactions

Patients are advised to consult a healthcare professional, such as a doctor or pharmacist, prior to using this medication if they are currently taking any prescription drugs.

Antacids have the potential to interact with various prescription medications, which may alter their effectiveness or lead to unintended side effects. It is essential for patients to disclose all medications they are taking to ensure safe and effective use of antacids. Monitoring for any changes in therapeutic effects or side effects is recommended when antacids are used concurrently with prescription drugs.

Packaging & NDC

Below are the non-prescription pack sizes of Equqline Extra Strength Antacid Assorted Fruit (calcium carbonate). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may use the medication as directed for symptom relief. The recommended dosage for this age group is to chew 2-4 tablets as symptoms occur, or as advised by a healthcare professional.

It is important to keep the medication out of reach of younger children to prevent accidental ingestion.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients receiving treatment. It is essential that patients with reduced creatinine clearance are closely monitored to ensure safety and efficacy. Renal function tests should be performed prior to the initiation of therapy and periodically during treatment to assess any changes in renal status. A reduced dose is recommended for patients with moderate to severe renal impairment to mitigate the risk of adverse effects. Additionally, special considerations should be taken into account for patients with end-stage renal disease, as their treatment may require further adjustments.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, and respiratory distress.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized until the patient stabilizes or further treatment is determined.

Documentation of the incident, including the substance involved, estimated dose, and time of ingestion, is vital for ongoing management and potential reporting requirements.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients not to exceed a maximum of 10 tablets within a 24-hour period. Additionally, patients should be informed that the maximum dosage of this product should not be used for more than 2 weeks unless directed by a healthcare professional.

It is also important for healthcare providers to encourage patients to consult with a doctor or pharmacist prior to use if they are currently taking any prescription medications. This is particularly crucial as antacids may interact with certain prescription drugs, potentially affecting their efficacy or safety.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature to ensure optimal conditions. Healthcare professionals are advised not to use the product if the printed seal under the cap is torn or missing, as this may indicate compromised safety or efficacy.

Additional Clinical Information

The medication is administered orally. Clinicians should advise patients to consult a doctor or pharmacist prior to use if they are currently taking any prescription medications, as antacids may interact with certain drugs. Additionally, patients who are pregnant or breastfeeding should seek professional guidance before using the medication.

Drug Information (PDF)

This file contains official product information for Equqline Extra Strength Antacid Assorted Fruit, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)